News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Mario Occhipinti: Target approach in pleural mesothelioma
Photo from Mario Occhipinti/X
Aug 22, 2024, 04:27

Mario Occhipinti: Target approach in pleural mesothelioma

Mario Occhipinti shared on X:

“Happy to share our latest article review on target approach in pleural mesothelioma! Check it out!”

https://x.com/mocchipintimd/status/1825976449486172163?s=46

Unleashing precision: a review of targeted approaches in pleural mesothelioma

Authors: Mario Occhipinti, Marta Brambilla, Raimondo Di Liello, Paolo Ambrosini, Lorenzo Lobianco, Rita Leporati, Maria Salvarezza, Fabiana Vitiello, Silvia Marchesi, Sara Manglaviti, Teresa Beninato, Laura Mazzeo, Claudia Proto, Arsela Prelaj, Roberto Ferrara, Carminia Maria Della Corte, Giuseppe Lo Russo, Filippo de Braud, Monica Ganzinelli, Giuseppe Viscardi

https://x.com/mocchipintimd/status/1825976449486172163?s=46

Source: Mario Occhipinti/X

Mario Occhipinti is a medical oncologist at theIRCCS Foundation National Cancer Institute of Milan. He completed his residency from the Sapienza University of Rome. He is a part of the AIOM Young Committee.

Arsela Prelaj cancer Carminia Maria Della Corte Claudia Proto Fabiana Vitiello Filippo de Braud Giuseppe Lo Russo Giuseppe Viscardi Laura Mazzeo Lorenzo Lobianco Maria Salvarezza Mario Occhipinti Marta Brambilla mesothelioma Monica Ganzinelli OncoDaily Oncology Paolo Ambrosini Raimondo Di Liello Rita Leporati Roberto Ferrara Sara Manglaviti Silvia Marchesi Teresa Beninato
Special Coverage
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been